Engineering B cells to express pathogen-specific antibodies to protect against infection
Antibodies are currently in use to treat diseases that range from cancer to autoimmunity and are usually administered to patients in multiple doses, much like medical drugs. However, the production and storage of antibodies are comparatively more expensive, with considerable interest on finding alternative strategies to deliver them. In a recent study, Howell F. Moffett and an interdisciplinary research team […]
Continue reading »